Dr. Mitchel Seruya, MD

Dr. Seruya practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Seruya's NPI, 1902030075, was assigned on May 5, 2009. Dr. Seruya graduated from Vagelos College of Physicians and Surgeons in 2006. Dr. Seruya holds California license A138160.

Dr. Seruya's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Seruya's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Seruya is also affiliated with Children's Hospital Los Angeles. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Seruya to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seruya practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Seruya's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Seruya is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Seruya's licenses on file in 7 states: California, Oregon, Arizona, New Mexico, Texas, District of Columbia and Virginia.

CMS data shows 390 Medicare services from Dr. Seruya across 9 procedure codes in 2024, for 165 Medicare patients. Medicare paid $66,515 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Seruya in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have arthritis, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seruya's median patient age at 62, with 49% women.

In 2022, Dr. Seruya wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $348 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Seruya for performance year 2024, reported as part of a group. Dr. Seruya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seruya as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Seruya, published from 2011 to 2023. 2016 was the busiest year, with 2. The most frequent topics are Craniosynostoses, Plastic Surgery Procedures and Osteotomy. Dr. Seruya has published most often in Plast Reconstr Surg. Dr. Seruya's most frequent co-authors are Robert F. Keating, MD, Gary Rogers, MD and Michael J. Boyajian, MD.

CMS Open Payments shows 13 general payments to Dr. Seruya from 6 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 76% of the total. AxoGen paid the most, $592.

Dmand AI lists 1 award for Dr. Seruya, most recently Top Docs in 2020.

Dr. Seruya graduated from Vagelos College of Physicians and Surgeons in 2006. Dr. Seruya is a member of American Association for Hand Surgery, American Society for Peripheral Nerve and ASPS.

Dr. Seruya is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.